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Abstract 
Objective: Generation of knockouts and in situ tagging of genes in Trypanosoma brucei has been greatly facilitated 
by using CRISPR/Cas9 as a genome editing tool. To date, this has entailed using a limited number of cell lines that are 
stably transformed to express Cas9 and T7 RNA polymerase (T7RNAP). It would be desirable, however, to be able to 
use CRISPR/Cas9 for any trypanosome cell line.
Results: We describe a sequential transfection expression system that enables transient expression of the two pro-
teins, followed by delivery of PCR products for gRNAs and repair templates. This procedure can be used for genome 
editing without the need for stable integration of the Cas9 and T7RNAP genes.
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Introduction
The establishment of genome editing by CRISPR/Cas9 
in trypanosomatids has greatly increased the ease with 
which knockouts can be generated, as two copies of a 
non-essential gene can often be deleted in a single round 
of transfection. The system most widely used for Trypa-
nosoma brucei entails creating cell lines which express 
(either constitutively or inducibly) both Cas9 to generate 
a DNA double-strand break and T7RNAP for the tran-
scription of guide RNAs from a DNA template [1–4]. 
The original pTB011 plasmid generated for T. brucei [4] 
encodes Cas9 flanked by tubulin sequences, enabling the 
construct to be integrated into the corresponding mul-
ticopy array. We modified this plasmid by replacing the 
puromycin acetyltransferase gene with that of T7RNAP, 
giving rise to pTB011_Cas9_T7RNAP_blast (Fig.  1a). 
This plasmid allows generation of CRISPR/Cas9-com-
petent cell lines, constitutively expressing T7RNAP and 
Cas9 from the tubulin locus, in a single round of trans-
fection [5]. Further modification of this plasmid, and 
optimisation of the transfection protocol for transient 




In order to expand the range of cell lines that can be 
genetically modified by CRISPR/Cas9, without the need 
for stable transformation, we developed a protocol for 
transient expression of all three components (Cas9, 
T7RNAP and guide RNAs) in T. brucei. The plasmid All-
in-one-Cas9 (pAi1C9; Fig. 1b) was constructed by replac-
ing the α-tubulin sequence upstream of T7RNAP with 
366 bp of the EP procyclin promoter and 5′ UTR [6].
To test the functionality of the plasmid, we used the 
LeishGEdit software [4] to design a guide RNA that 
allows tagging of the C-terminus of phosphodiesterase 
B1 (PDEB1) with mNeonGreen (mNG). The repair tem-
plate, in the form of a purified PCR product, including 
homology arms of 30 bp on each side, was amplified from 
pPOTv7 [7]. As a positive control we transfected a deriv-
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expresses Cas9 and T7RNAP constitutively (Lister 427/
Cas9) [5]. This gave rise to cells with a fluorescent flagel-
lum as expected (tryptag.org) (Fig. 2a).
For genome editing by transient expression of Cas9 and 
T7RNAP, we tested two different transfection schemes. 
Initially, all components were transfected simultane-
ously: the circular plasmid pAi1C9 encoding Cas9 and 
T7RNAP, the DNA template for in  vivo transcription 
of a guide RNA, and the DNA repair template harbour-
ing mNG for C-terminal tagging and a hygromycin 
resistance gene. This procedure gave few hygromycin-
resistant clones, only 10 clones in total, from 4 separate 
transfections. These clones either did not express mNG 
(4 clones), or expressed it as a cytoplasmic protein (2 
clones) or expressed it correctly localised to the flagellum 
(4 clones). Examples are shown in Fig.  2b. We hypoth-
esise that, due to insufficient expression of Cas9 and 
T7RNAP, the amounts of site-specific guide RNAs and 
double-strand breaks at the correct locus were too low to 
drive efficient integration by homology-directed repair.
We therefore tested sequential transfections in which 
we first used pAi1C9 to enable expression of Cas9 and 
T7RNAP. A second transfection 20 h later provided the 
templates for the gRNA and the mNG repair construct. 
The same electroporation conditions were used for the 
plasmid and the templates (see Methods and Fig.  3). 
This procedure yielded 20 clones. There were 16 clones 
in which mNG was correctly localised to the flagellum, 
one in which it was cytoplasmic, 2 clones with mixed 
populations of mNG localised either to the flagellum or 
the cytoplasm, and one that was negative (see Fig.  2b 
for representative examples). One clone with flagel-
lar mNeonGreen had a fluorescence intensity twice that 
of the others (clone B1) and might have been tagged on 
both alleles.
We have also used this procedure of sequential trans-
fections to simultaneously knock out both copies of 
trypanin or GPI-anchor transamidase subunit 8 (GPI8), 
which are non-essential genes in cultured procyclic form 




4 × 107 T. b. brucei 427 procyclic forms were transfected 
with 10  µg pAi1C9 dissolved in 100  µl TbBSF trans-
fection buffer [10], using an Amaxa Nucleofector IIb 
(Lonza), program X-014 [11]. Cells were transferred to 
13 ml SDM79 medium [12] supplemented with 10% FBS 
and incubated at 27 °C and 2.5%  CO2 for 20 h.
Transfection of pooled PCR products for repair constructs 
and sgRNA templates
The entire culture from the first transfection was cen-
trifuged at 1700 g for 5 min, the supernatant discarded 
and the cells resuspended in 100 µl TbBSF transfection 
buffer containing the pooled PCR products (see proto-
col for PCRs below). For tagging one sgRNA template 
(targeted to the 3′ end of the ORF) and one repair tem-
plate (hygromycin resistance) were provided; to gener-
ate the knockouts, we provided two sgRNA templates 
(targeted to the 5′ and 3′ ends of the ORF) and two 
repair templates (hygromycin and neomycin resistance 
genes).
Transfection was performed as described above and 
the cells were transferred to 10  ml SDM79 supple-






Fig. 1 Plasmid maps of a pTB011_Cas9_T7RNAP_blast and b pAi1C9
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Fig. 2 Trypanosomes tagged with mNeonGreen at the C-terminus of phosphodiesterase B1 (PDEB1). a Tagging PDEB1 in Lister 427/Cas9. Scale bar: 
10 microns. b Tagging PDEB1 in Lister 427. Fluorescence intensity of live cells was quantified with a benchtop flow cytometer (ACEA NovoCyte). To 
remove particles of subcellular size, a cut-off of 3 x 104 was applied to the forward scatter. A total of  104 events were recorded and analysed using 
FlowJo software without gating. TF transfection
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and 1:500 in conditioned medium (fresh medium + 20% 
supernatant of a log-phase culture) and distributed 
into 24-well plates (1  ml in each well). Transformants 
were selected using 25   µg   ml−1  Hygromycin B and/
or 15   µg   ml−1  Geneticin; stable clones were obtained 
2 weeks post selection.
Polymerase chain reactions (PCR)
Reactions were performed with reagents from New 
England Biolabs: Phusion High-Fidelity DNA poly-
merase (M0530S), 5 x  Phusion HF buffer (B0519S) and 
dNTP mix (N0447S). Cycling conditions are identical 
to those previously published [4, 13].
– 1st PCR: template for sgRNAs; two 20 µl reactions 
per target.
1 μl G00 primer (0.5 μM)
4 μl 5 x Phusion HF buffer
0.5 μl dNTP mix (250 μM)
1 μl sgRNA primer (0.5 μM)








5) go to step 2, 35 cycles in total
6) 10′, 72 °C
7) hold at 10 °C
B KnockoutA In situ tagging
Fig. 3 Flow chart of sequential transfections. Procyclic form trypanosomes were transfected first with pAi1C9 to allow expression of Cas9 and 
T7RNAP. After 20 h, the pool of trypanosomes was transfected a second time to provide the templates for gRNA(s) and the repair template(s)/
resistance cassette(s)
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– 2nd PCR: template for resistance gene; two 40  µl 
reactions per resistance gene
2 μl 60 ng pPOTv7 mNG (hygro or G418) plasmid
8 μl 5 x Phusion HF buffer
1 μl dNTP mix (250 μM)
2 μl Upstream forward primer (0.5 μM)
2 μl Downstream reverse KO/TAG primer (0.5 μM)







5) go to step 2, 40 cycles in total
6) 10′, 72 °C
7) hold at 10 °C
DNA purification after PCR
PCR reactions were pooled and extracted with 1 volume 
water-saturated phenol (pH 8), followed by extraction 
with 1 volume chloroform. DNA was precipitated from 
the aqueous phase by addition of 0.1 volume 3 M sodium 
acetate, pH 5.2, and 3 volumes ice-cold ethanol. The 
DNA was pelleted by centrifugation, washed twice with 
1  ml 80% ethanol, air-dried at room temperature, dis-





PDEB1 3′ sgRNA primer:
gaaattaatacgactcactataggTGA AGA AGT CAG TTG ACC 
GGgttttagagctagaaatagc
Trypanin 5′ sgRNA primer:
gaaattaatacgactcactataggCAA AAA CGA GAA GAG 
CCT ACgttttagagctagaaatagc
Trypanin 3′ sgRNA primer:
gaaattaatacgactcactataggAGG TGT TGT GGT TCA CAC 
GTgttttagagctagaaatagc
GPI8 5′ sgRNA primer:
gaaattaatacgactcactataggCGG TTG CAA AAA ACG AAT 
GCgttttagagctagaaatagc
GPI8 3′ sgRNA primer:
gaaattaatacgactcactataggGGT ATG TCC CAT CAG TTG 
GAgttttagagctagaaatagc
Trypanin upstream forward primer:
TAC TTT TCA GAC TGC ATC GTG GCG TAC CCC 
gtataatgcagacctgctgc
Trypanin downstream reverse KO primer:
CTG CAA CAA AGC CGT AAC TTG GAA CAA CCA 
ccggaaccactaccagaacc
PDEB1 downstream forward primer:
ACG AGT TCT GGC AAC AAC AGC AGT ACT CGT 
ggttctggtagtggttccgg
PDEB1 downstream reverse TAG:
ATC ACC ATT GAC AAG AAC GTA CAT CTA CCA 
ccaatttgagagacctgtgc
GPI8 upstream forward primer:
TTG GAT CAG GCG CTT GCA TAT TTA TTT CCA 
gtataatgcagacctgctgc
GPI8 downstream reverse KO primer:
AGT TTC AGG AAG GAA GTT CGT TTT TCT CCT 
ccggaaccactaccagaacc
Limitations
Transient transfection with pAi1C9 gives rise to fewer 
clones than cell lines that are stably transformed with the 
T7RNAP and Cas9 genes. It has the advantage, however, 
that it can be applied to any T. brucei cell line. Moreo-
ver, in contrast to stable integration of the CRISPR/Cas9 
machinery, transient transfection does not require addi-
tional selectable markers and it has the added advantage 
that it circumvents possible Cas9 toxicity. In addition to 
using Cas9 for deletion, mutation, tagging or integration 
of ectopic copies, this procedure could also be adapted 
for nuclease inactive Cas9 variants for targeting RNAs or 
epigenetic modifications [14, 15].
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Additional file 1: Validation of knockout (KO) clones. A+B Trypanin-KO 
(Tb427.10.6350). A Clonal selection of stable transformants in 24-well 
plates. Dilutions from transfected pool cultures and number of cells 
seeded are indicated. Circles depict wells containing cells with success-
ful ( ) or unsuccessful (○) genome editing. B Assessment of editing 
by genotyping PCR and agarose gel electrophoresis. Genes amplified 
from genomic DNA and target loci are indicated. Lanes corresponding 
to validated KO clones are marked with green circles. C+D GPI8-KO 
(Tb427.10.13860) in a cell line allowing inducible expression of an ectopic 
copy of GPI8. C as in A. D as in B. E List of primers used for genotyping 
PCRs of Trypanin-KO (left panels) and GPI8-KO (right panels).
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